Ovid Therapeutics Inc. (OVID) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6904691010
Ovid Therapeutics Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 7.25 m USD |
| Operating income | -42.44 m USD |
| EBIT | -19.44 m USD |
| Net income | -17.41 m USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ovid Therapeutics Inc.
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
More stocks
- MHA PLC (MHA.L)
- Restore PLC (RST.L)
- Beijing ConST Instruments Technology Inc (300445.SZ)
- ALUMIS INC. (ALMS)
- Ability Opto-Electronics Technology Co Ltd (3362.TWO)
- Hainan Haiqi Transportation Group Co Ltd (603069.SS)
- MHP SE (MHPC.L)
- Visco Vision Inc. (6782.TW)
- Yupi Indo Jelly Gum PT Tbk (YUPI.JK)
- Beijing Science Sun Pharmaceutical Co Ltd (300485.SZ)
- Invengo Information Technology Co Ltd (002161.SZ)
- Puyang Refractories Group Co Ltd (002225.SZ)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.